
Sergio Coffa
Examiner (ID: 9524, Phone: (571)270-3022 , Office: P/1675 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1676, 1658, 1654, 1675 |
| Total Applications | 897 |
| Issued Applications | 440 |
| Pending Applications | 134 |
| Abandoned Applications | 351 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8042259
[patent_doc_number] => 20120070856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'CROSS-LINKING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/254500
[patent_app_country] => US
[patent_app_date] => 2010-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12759
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20120070856.pdf
[firstpage_image] =>[orig_patent_app_number] => 13254500
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/254500 | CROSS-LINKING AGENTS | Mar 3, 2010 | Abandoned |
Array
(
[id] => 6025766
[patent_doc_number] => 20110053837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'Mineral-peptide chelates'
[patent_app_type] => utility
[patent_app_number] => 12/659241
[patent_app_country] => US
[patent_app_date] => 2010-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 2436
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053837.pdf
[firstpage_image] =>[orig_patent_app_number] => 12659241
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/659241 | Mineral-peptide chelates | Mar 1, 2010 | Abandoned |
Array
(
[id] => 9239175
[patent_doc_number] => 08603966
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Amino acid-based compounds, their methods of use, and methods of screening'
[patent_app_type] => utility
[patent_app_number] => 13/203490
[patent_app_country] => US
[patent_app_date] => 2010-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10485
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13203490
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/203490 | Amino acid-based compounds, their methods of use, and methods of screening | Feb 26, 2010 | Issued |
Array
(
[id] => 8042329
[patent_doc_number] => 20120070897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'Method For Enucleating Nucleated Erythrocyte, And Enucleation Inducer'
[patent_app_type] => utility
[patent_app_number] => 13/202852
[patent_app_country] => US
[patent_app_date] => 2010-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11294
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20120070897.pdf
[firstpage_image] =>[orig_patent_app_number] => 13202852
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/202852 | Method for enucleating nucleated erythrocyte, and enucleation inducer | Feb 22, 2010 | Issued |
Array
(
[id] => 7807236
[patent_doc_number] => 20120058190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'FOOD CONTAINING PROLACTIN'
[patent_app_type] => utility
[patent_app_number] => 13/201941
[patent_app_country] => US
[patent_app_date] => 2010-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9927
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058190.pdf
[firstpage_image] =>[orig_patent_app_number] => 13201941
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201941 | FOOD CONTAINING PROLACTIN | Feb 16, 2010 | Abandoned |
Array
(
[id] => 8313595
[patent_doc_number] => 20120190625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'NOVEL PEPTIDE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/389051
[patent_app_country] => US
[patent_app_date] => 2010-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5725
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389051
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/389051 | Peptide and use thereof | Feb 11, 2010 | Issued |
Array
(
[id] => 7568217
[patent_doc_number] => 20110288280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'COELENTERAMIDE ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 13/146710
[patent_app_country] => US
[patent_app_date] => 2010-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22351
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288280.pdf
[firstpage_image] =>[orig_patent_app_number] => 13146710
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/146710 | Coelenteramide analogs | Feb 7, 2010 | Issued |
Array
(
[id] => 7587282
[patent_doc_number] => 20110281792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'BINDING-SITE MODIFIED LECTINS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/145528
[patent_app_country] => US
[patent_app_date] => 2010-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 64438
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281792.pdf
[firstpage_image] =>[orig_patent_app_number] => 13145528
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145528 | BINDING-SITE MODIFIED LECTINS AND USES THEREOF | Jan 26, 2010 | Abandoned |
Array
(
[id] => 9957966
[patent_doc_number] => 09006170
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => 'Compositions for elastogenesis and connective tissue treatment'
[patent_app_type] => utility
[patent_app_number] => 12/686330
[patent_app_country] => US
[patent_app_date] => 2010-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16401
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12686330
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/686330 | Compositions for elastogenesis and connective tissue treatment | Jan 11, 2010 | Issued |
Array
(
[id] => 7720814
[patent_doc_number] => 20120010149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'PEPTIDE COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 13/142931
[patent_app_country] => US
[patent_app_date] => 2009-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4998
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010149.pdf
[firstpage_image] =>[orig_patent_app_number] => 13142931
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142931 | Peptide combination | Dec 29, 2009 | Issued |
Array
(
[id] => 7670052
[patent_doc_number] => 20110319321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'MAMMALIAN COLOSTRUM DERIVED NANOPEPTIDES FOR BROADSPECTRUM VIRAL AND RECURRENT INFECTIONS WITH A METHOD OF ISOLATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/142327
[patent_app_country] => US
[patent_app_date] => 2009-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4237
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13142327
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142327 | Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof | Dec 28, 2009 | Issued |
Array
(
[id] => 8920953
[patent_doc_number] => 08486885
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-16
[patent_title] => 'β-arrestin effectors and compositions and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/647810
[patent_app_country] => US
[patent_app_date] => 2009-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19611
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12647810
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/647810 | β-arrestin effectors and compositions and methods of use thereof | Dec 27, 2009 | Issued |
Array
(
[id] => 9020421
[patent_doc_number] => 08530406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-10
[patent_title] => 'HMG-CoA reductase derived peptide and cosmetic or pharmaceutical composition containing same'
[patent_app_type] => utility
[patent_app_number] => 13/141123
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6379
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141123
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141123 | HMG-CoA reductase derived peptide and cosmetic or pharmaceutical composition containing same | Dec 22, 2009 | Issued |
Array
(
[id] => 6443612
[patent_doc_number] => 20100144597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Novel combinatorial approaches to enhancing oxygen transport to tissues'
[patent_app_type] => utility
[patent_app_number] => 12/653343
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5230
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144597.pdf
[firstpage_image] =>[orig_patent_app_number] => 12653343
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/653343 | Novel combinatorial approaches to enhancing oxygen transport to tissues | Dec 9, 2009 | Abandoned |
Array
(
[id] => 8063731
[patent_doc_number] => 20110245156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'NOVEL ANTIVIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/133492
[patent_app_country] => US
[patent_app_date] => 2009-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17677
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245156.pdf
[firstpage_image] =>[orig_patent_app_number] => 13133492
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/133492 | NOVEL ANTIVIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | Dec 8, 2009 | Abandoned |
Array
(
[id] => 7756653
[patent_doc_number] => 20120028881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'METHODS AND REAGENTS FOR DIAGNOSING ATHEROMA'
[patent_app_type] => utility
[patent_app_number] => 13/132828
[patent_app_country] => US
[patent_app_date] => 2009-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16603
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028881.pdf
[firstpage_image] =>[orig_patent_app_number] => 13132828
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/132828 | METHODS AND REAGENTS FOR DIAGNOSING ATHEROMA | Dec 2, 2009 | Abandoned |
Array
(
[id] => 7696170
[patent_doc_number] => 20110230420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'RELEASABLE CONJUGATES FOR NUCLEIC ACIDS DELIVERY SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 13/129705
[patent_app_country] => US
[patent_app_date] => 2009-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25724
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230420.pdf
[firstpage_image] =>[orig_patent_app_number] => 13129705
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129705 | RELEASABLE CONJUGATES FOR NUCLEIC ACIDS DELIVERY SYSTEMS | Nov 16, 2009 | Abandoned |
Array
(
[id] => 7561722
[patent_doc_number] => 20110275555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'COMPOSITIONS CONTAINING DELTA-9-THC-AMINO ACID ESTERS AND PROCESS OF PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 13/126606
[patent_app_country] => US
[patent_app_date] => 2009-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 6996
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275555.pdf
[firstpage_image] =>[orig_patent_app_number] => 13126606
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/126606 | Compositions containing delta-9-THC-amino acid esters and process of preparation | Nov 1, 2009 | Issued |
Array
(
[id] => 7574012
[patent_doc_number] => 20110269668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'Fused Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/123002
[patent_app_country] => US
[patent_app_date] => 2009-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7321
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269668.pdf
[firstpage_image] =>[orig_patent_app_number] => 13123002
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/123002 | Fused heteroaryl diamide compounds useful as MMP-13 inhibitors | Oct 12, 2009 | Issued |
Array
(
[id] => 7511372
[patent_doc_number] => 20110257082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'HIV-1 INTEGRASE DERIVED STIMULATORY PEPTIDES INTERFERING WITH INTEGRASE -- REV PROTEIN BINDING'
[patent_app_type] => utility
[patent_app_number] => 13/122548
[patent_app_country] => US
[patent_app_date] => 2009-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12426
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257082.pdf
[firstpage_image] =>[orig_patent_app_number] => 13122548
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/122548 | HIV-1 integrase derived stimulatory peptides interfering with integrase—Rev protein binding | Sep 30, 2009 | Issued |